Effects of neuropeptide FF and related peptides on the antinociceptive activities of VD-hemopressin(α) in naive and cannabinoid-tolerant mice.
Explore this paper's citation graph
Summary
The present works support the cannabinoid-modulating character of NPFF system in naive and cannabinoid-tolerant mice and suggest that a chronic cannabinoid treatment modifies the pharmacological profiles ofNPFF, but not the cannabinoids-potentiating effects of neuropeptide VF and dNPA.
- Type
- article
- Published
- 2015-11-15
- Cited by
- 9
- References
- 42
- OpenAlex
- https://openalex.org/W26472125
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:23645280
Keywords
Context (archaeology), Sociology, Psychology, Epistemology, History
References
- Neuropeptide VF Enhances Cannabinoid Agonist WIN55,212-2-Induced Antinociception in Mice
- Effects of Chronic Treatment with Δ9-Tetrahydrocannabinol on Cannabinoid-Stimulated [35S]GTPγS Autoradiography in Rat Brain
- The endocannabinoid system in renal cells: regulation of Na+ transport by CB1 receptors through distinct cell signalling pathways
- Changes in CNS neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment.
- Cannabinoid receptors and pain.
- Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists.
- Correction for Simonin et al., RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia
- The N-terminal domain of human hemokinin-1 influences functional selectivity property for tachykinin receptor neurokinin-1.
- Anti-analgesia of a selective NPFF2 agonist depends on opioid activity.
- Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice.
- Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception.
- Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen.
- Neuropeptide FF, pain and analgesia.
- Opposite Effects of Neuropeptide FF on Central Antinociception Induced by Endomorphin-1 and Endomorphin-2 in Mice
- Antinociceptive Effects of Central Administration of the Endogenous Cannabinoid Receptor Type 1 Agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(α)], an N-Terminally Extended Hemopressin Peptide
- Cannabinoid-opioid interactions during neuropathic pain and analgesia
- Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine.
- Modulation of the cannabinoid receptors by hemopressin peptides
- Hemopressin is an inverse agonist of CB1 cannabinoid receptors
- Molecular characterization of a peripheral receptor for cannabinoids
Cited by
- Investigation of receptor binding and functional characteristics of hemopressin(1-7).
- Intracellular Peptides in Cell Biology and Pharmacology
- Signaling molecules targeting cannabinoid receptors: Hemopressin and related peptides.
- Targeting the cannabinoid and mu opioid receptors with heterodimerized and allosteric ligands
- VF-13, a chimeric peptide of VD-hemopressin(α) and neuropeptide VF, produces potent antinociception with reduced cannabinoid-related side effects.
- Hemopressin as a breakthrough for the cannabinoid field
- New Insights Into Peptide Cannabinoids: Structure, Biosynthesis and Signaling
- Characterization of pepcan-23 as pro-peptide of RVD-hemopressin (pepcan-12) and stability of hemopressins in mice.
- MPN-12-NH2 shows potent antinociception effects by targeting opioid, cannabinoid, and neuropeptide FF receptors.
Related papers
- Conceptual and methodological problems in studying the effects of interdisciplinary geriatric teams.
- Methodological issues in geriatric research.
- THE POLITICAL APPROACH TO GERIATRIC PROBLEMS
- RESEARCH ON HUMAN POTENTIALITIES: APPLICATION TO GERIATRIC PROGRAMS
- Seizing interdisciplinary opportunities in the changing landscape of health and aging: a social work perspective.